A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment for ...

There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Back pain is among the most common forms of pain patients endure, and can severely alter their quality of life and ability to ...

Inactive patients were at a higher risk for inactivity-related comorbid conditions, including obesity and diabetes, as well ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

The commercialisation of junk food, increase in inactive lifestyles with prolonged sitting, and high stress environments, ...

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...